Analysis of medicine advertisement produced in Brazil
Fuente:
Redalyc
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Centro de investigaciones y Publicaciones Farmacéuticas
2007
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1876485436420915200 |
|---|---|
| author | Lorilei de Fátima Wzorek |
| author_facet | Lorilei de Fátima Wzorek |
| contents | Analysis of medicine advertisement produced in Brazil Lorilei de Fátima Wzorek Angela C. Badaró Trindade Cassyano J. Correr Roberto Pontarolo Medicina Brazil Advertising Periodicals Drug Industry Objective: To analyze the compliance of drugadvertisements with regulations in Brazil, subject toResolution RDC No. 102/2000 since 2000, whichabides by the WHOs (World Health Organization)Ethical Criteria for Medicinal Drug Promotion,published in 1988.Methods: Drug advertisements running within theperiod of October 2002 to October 2003 werecollected and recorded. Media sources includedvarious AM and FM radio stations, televisionchannels, newspapers, and magazines, as well asprinted material distributed in doctors offices,hospitals, drugstores, conferences, billboards, andbus doors. All sources were located in Curitiba City,Brazil, and its surrounding area. Advertisementcontent was analyzed according to a conformitychecklist prepared based on the legal requirementsof RDC No. 102/00.Results: A total of 827 advertisements for 517different products, 83.91% regularly registered asmedicinal drugs and 16.09% unregistered productsthat should be registered according to the Brazilianregulations, were recorded and collected.Approximately 74.73% of the advertisements did notcomply with regulations; on average, suchadvertisements had 4.6 infractions each.Conclusions: The results of this research suggestthat RDC No. 102/00 is not followed, whichstrengthens the need to adopt new forms ofregulation to prohibit excesses of thepharmaceutical industry and to protect thepopulation from abusive and misleading drugadvertising 2007 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69050302 https://www.redalyc.org/journal/690/69050302/ https://www.redalyc.org/journal/690/69050302/html/ https://www.redalyc.org/journal/690/69050302/69050302.epub https://www.redalyc.org/journal/690/69050302/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.3 Vol.5 |
| format | Artículo científico |
| id | redalyc_69050302 |
| institution | Redalyc |
| language | en |
| publishDate | 2007 |
| publisher | Centro de investigaciones y Publicaciones Farmacéuticas |
| spellingShingle | Analysis of medicine advertisement produced in Brazil Lorilei de Fátima Wzorek Medicina Brazil Advertising Periodicals Drug Industry Analysis of medicine advertisement produced in Brazil Lorilei de Fátima Wzorek Angela C. Badaró Trindade Cassyano J. Correr Roberto Pontarolo Medicina Brazil Advertising Periodicals Drug Industry Objective: To analyze the compliance of drugadvertisements with regulations in Brazil, subject toResolution RDC No. 102/2000 since 2000, whichabides by the WHOs (World Health Organization)Ethical Criteria for Medicinal Drug Promotion,published in 1988.Methods: Drug advertisements running within theperiod of October 2002 to October 2003 werecollected and recorded. Media sources includedvarious AM and FM radio stations, televisionchannels, newspapers, and magazines, as well asprinted material distributed in doctors offices,hospitals, drugstores, conferences, billboards, andbus doors. All sources were located in Curitiba City,Brazil, and its surrounding area. Advertisementcontent was analyzed according to a conformitychecklist prepared based on the legal requirementsof RDC No. 102/00.Results: A total of 827 advertisements for 517different products, 83.91% regularly registered asmedicinal drugs and 16.09% unregistered productsthat should be registered according to the Brazilianregulations, were recorded and collected.Approximately 74.73% of the advertisements did notcomply with regulations; on average, suchadvertisements had 4.6 infractions each.Conclusions: The results of this research suggestthat RDC No. 102/00 is not followed, whichstrengthens the need to adopt new forms ofregulation to prohibit excesses of thepharmaceutical industry and to protect thepopulation from abusive and misleading drugadvertising 2007 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69050302 https://www.redalyc.org/journal/690/69050302/ https://www.redalyc.org/journal/690/69050302/html/ https://www.redalyc.org/journal/690/69050302/69050302.epub https://www.redalyc.org/journal/690/69050302/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.3 Vol.5 |
| title | Analysis of medicine advertisement produced in Brazil |
| topic | Medicina Brazil Advertising Periodicals Drug Industry |
| url | https://www.redalyc.org/articulo.oa?id=69050302 https://www.redalyc.org/journal/690/69050302/ https://www.redalyc.org/journal/690/69050302/html/ https://www.redalyc.org/journal/690/69050302/69050302.epub https://www.redalyc.org/journal/690/69050302/movil |